Koji Yamada

Title: Koji Yamada: Innovator in Thrombin Composition

Introduction

Koji Yamada is a notable inventor based in Shinjuku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombin compositions for medical use. His innovative work focuses on creating effective solutions for treating hemorrhage.

Latest Patents

Yamada holds a patent for a thrombin composition designed for oral administration. This stable thrombin composition includes thrombin as a hemostatic ingredient, along with gelatin, albumin, and glycine as stabilizers. Additionally, sucrose and/or sugar alcohol serve as carriers. This formulation is particularly effective for treating hemorrhage in the upper alimentary canal. It remains stable at room temperature for extended periods and boasts excellent solubility, allowing for simple oral administration.

Career Highlights

Yamada is associated with Mochida Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical innovations. His work has garnered attention for its potential impact on medical treatments and patient care.

Collaborations

Yamada collaborates with talented colleagues, including Yasuyuki Kunihiro and Ryo Tanaka. Their combined expertise contributes to the success of their projects and the development of innovative solutions in the pharmaceutical industry.

Conclusion

Koji Yamada's contributions to thrombin compositions highlight his role as an innovator in the pharmaceutical field. His work not only addresses critical medical needs but also showcases the importance of collaboration in advancing healthcare solutions.